Concepedia

Hind Rafei

HR

24

Publications

1.2K

Citations

16

H-Index

2015

Active since

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

George Washington University

Technical University of Munich

The University of Texas Health Science Center at Houston

University of Miami

Hind Rafei is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, immunology, and immunotherapy.

ORCID

Top concepts

Publications per year

2015–2025

24

Publications

24

Safety, efficacy and determinants of response of allogeneic CD19-specific CAR-NK cells in CD19+ B cell tumors: a phase 1/2 trial

David Marín, Ye Li, Rafet Başar et al. · Nature Medicine · 2024 · 376 citations · Full text

KIR-based inhibitory CARs overcome CAR-NK cell trogocytosis-mediated fratricide and tumor escape

Ye Li, Rafet Başar, Guohui Wang et al. · Nature Medicine · 2022 · 152 citations · Full text

, , +10

Loss of metabolic fitness drives tumor resistance after CAR-NK cell therapy and can be overcome by cytokine engineering

Li Li, Vakul Mohanty, Jinzhuang Dou et al. · Science Advances · 2023 · 94 citations · Full text

, , +18

Allogeneic Hematopoietic Stem Cell Transplantation for GATA2 Deficiency Using a Busulfan-Based Regimen

Mark Parta, Nirali N. Shah, Kristin Baird et al. · Biology of Blood and Marrow Transplantation · 2018 · 86 citations · Full text

Third-Party BK Virus-Specific Cytotoxic T Lymphocyte Therapy for Hemorrhagic Cystitis Following Allotransplantation

Amanda Olson, Ruitao Lin, David Marín et al. · Journal of Clinical Oncology · 2021 · 63 citations · Full text

Rows per page

1–5 of 24